StockData
Merck & Co., Inc. logo

Merck & Co., Inc.

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)

Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%

Merck Other Revenues — U.S. by Year

Other Revenues — U.S. ($M) ($M)

Merck Other Revenues — U.S.: $148M in FY2025, up 17.5% from a year earlier.

Latest, FY2025
148
Period ended Dec 31, 2025
Change on a year earlier
+17.5%
126 in FY2024
History
10 years
Since FY2016
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Other Revenues (9) | 515 | 891 | -42 | 148 | 126 | 17 | 367 | 765 | -52”

Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗

Reported in Form 8-K Table 3a / 3b.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Merck Other Revenues — U.S. ($M), annual FY2016–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-other-revenues-us

See every metric in the Merck KPI table. Data updated Oct 26, 2026.